Intended for healthcare professionals
Our CompanySubscribeMy AccountLogin

Did the FDA break its own rules in approving the antibiotic Recarbrio?

FDA
FDA

Did the FDA break its own rules in approving the antibiotic Recarbrio?

FDA scientists said that they couldn’t draw any inferences from the clinical trials for a new combination antibiotic from Merck—but the agency approved Recarbrio anyway. Peter Doshi investigates

OpinionThe decline of science at the FDA has become unmanageable
Woman with persistent acne
Effectiveness of spironolactone for women with acne vulgaris

In this study, Santer and colleagues designed a pragmatic trial to inform real world decision making for women with acne and to reflect the potential role of spironolactone

research  |  May 16
Effectiveness of spironolactone for women with acne vulgaris

In this study, Santer and colleagues designed a pragmatic trial to inform real world decision making for women with acne and to reflect the potential role of spironolactone

Woman with persistent acne
research

May 16

Latest articles

News

NHS strikes

UK Jobs

Fiona Stanley Fremantle Hospitals Group: Service Medical Registrar SMHS

Current issue

latest issue
All articlesPast issues

Most read

1.

Community

Latest responses

View more

What are your thoughts?

Altmetrics

Altmetric Badge
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial: Video 1
Nov 2, 2021